256 related articles for article (PubMed ID: 25751798)
21. Rural-Urban Differences in Medicare Quality Outcomes and the Impact of Risk Adjustment.
Henning-Smith C; Kozhimannil K; Casey M; Prasad S; Moscovice I
Med Care; 2017 Sep; 55(9):823-829. PubMed ID: 28800000
[TBL] [Abstract][Full Text] [Related]
22. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
23. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
24. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
25. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
Johnson AM; Hines RB; Johnson JA; Bayakly AR
Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
[TBL] [Abstract][Full Text] [Related]
26. Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer.
Ray MA; Faris NR; Derrick A; Smeltzer MP; Osarogiagbon RU
Chest; 2020 Aug; 158(2):787-796. PubMed ID: 32387525
[TBL] [Abstract][Full Text] [Related]
27. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
28. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL
J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878
[TBL] [Abstract][Full Text] [Related]
29. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.
Wray CM; Ziogas A; Hinojosa MW; Le H; Stamos MJ; Zell JA
Dis Colon Rectum; 2009 Aug; 52(8):1359-66. PubMed ID: 19617745
[TBL] [Abstract][Full Text] [Related]
30. Disparities in Colon Cancer Survival by Insurance Type: A Population-Based Analysis.
Pulte D; Jansen L; Brenner H
Dis Colon Rectum; 2018 May; 61(5):538-546. PubMed ID: 29624548
[TBL] [Abstract][Full Text] [Related]
31. Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base.
Becerra AZ; Berho ME; Probst CP; Aquina CT; Tejani MA; Gonzalez MG; Xu Z; Swanger AA; Noyes K; Monson JR; Fleming FJ
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):674-683. PubMed ID: 27613558
[TBL] [Abstract][Full Text] [Related]
32. Lymph node involvement in colon cancer patients decreases with age; a population based analysis.
Khan H; Olszewski AJ; Somasundar P
Eur J Surg Oncol; 2014 Nov; 40(11):1474-80. PubMed ID: 25027280
[TBL] [Abstract][Full Text] [Related]
33. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.
Law CH; Wright FC; Rapanos T; Alzahrani M; Hanna SS; Khalifa M; Smith AJ
J Surg Oncol; 2003 Nov; 84(3):120-6. PubMed ID: 14598354
[TBL] [Abstract][Full Text] [Related]
34. Quality of prostate cancer care among rural men in the Veterans Health Administration.
Skolarus TA; Chan S; Shelton JB; Antonio AL; Sales AE; Malin JL; Saigal CS
Cancer; 2013 Oct; 119(20):3629-35. PubMed ID: 23913676
[TBL] [Abstract][Full Text] [Related]
35. The metastatic lymph node ratio predicts survival in colon cancer.
Schumacher P; Dineen S; Barnett C; Fleming J; Anthony T
Am J Surg; 2007 Dec; 194(6):827-31; discussion 831-2. PubMed ID: 18005779
[TBL] [Abstract][Full Text] [Related]
36. Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer.
Muralidhar V; Nipp RD; Ryan DP; Hong TS; Nguyen PL; Wo JY
Dis Colon Rectum; 2016 Mar; 59(3):187-93. PubMed ID: 26855392
[TBL] [Abstract][Full Text] [Related]
37. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival.
Moore J; Hyman N; Callas P; Littenberg B
Surgery; 2010 Mar; 147(3):358-65. PubMed ID: 19962166
[TBL] [Abstract][Full Text] [Related]
38. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
[TBL] [Abstract][Full Text] [Related]
39. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer.
Chen SL; Steele SR; Eberhardt J; Zhu K; Bilchik A; Stojadinovic A
Ann Surg; 2011 Jan; 253(1):82-7. PubMed ID: 21135690
[TBL] [Abstract][Full Text] [Related]
40. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.
Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY
Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
